| Issue Date | Title | Author(s) |
| - | Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases | Chan, Y; Raju Allam, VSR; Paudel, KR; Singh, SK; Gulati, M; Dhanasekaran, M; Gupta, PK; Jha, NK; Devkota, HP; Gupta, G; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| - | Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases | Devkota, HP; Paudel, KR; Jha, NK; Gupta, PK; Singh, SK; Chellappan, DK; Hansbro, PM; Dua, K |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
| 2021-10 | Development and validation of RP-HPLC method for 1΄-Acetoxychavicol acetate (ACA) and its application in optimizing the yield of ACA during its isolation from Alpinia galanga extract as well as its quantification in nanoemulsion | Ramanunny, AK; Wadhwa, S; Gulati, M; Gupta, S; Porwal, O; Jha, NK; Gupta, PK; Kumar, D; Prasher, P; Dua, K; Saqr, AA; Almawash, S; Singh, SK |
| 2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
| 2021-01 | Induction of Caspase-Mediated Apoptosis in HepG2 Liver Carcinoma Cells Using Mutagen-Antioxidant Conjugated Self-Assembled Novel Carbazole Nanoparticles and In Silico Modeling Studies. | Anand, K; Abdul, NS; Ghazi, T; Ramesh, M; Gupta, G; Tambuwala, MM; Dureja, H; Singh, SK; Chellappan, DK; Dua, K; Pandi, B; Saravanan, M; Chuturgoon, AA |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-11 | Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges | Kumbhar, P; Manjappa, A; Shah, R; Jha, NK; Singh, SK; Dua, K; Disouza, J; Patravale, V |
| 2022-01-01 | A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers | Charbe, NB; Castillo, F; Tambuwala, MM; Prasher, P; Chellappan, DK; Carreño, A; Satija, S; Singh, SK; Gulati, M; Dua, K; González-Aramundiz, JV; Zacconi, FC |
| - | Folic Acid Functionalized Diallyl Trisulfide–Solid Lipid Nanoparticles for Targeting Triple Negative Breast Cancer | De, A; Roychowdhury, P; Bhuyan, NR; Ko, YT; Singh, SK; Dua, K; Kuppusamy, G |
